PNC Financial Services Group
NPCE icon

PNC Financial Services Group’s Neuropace NPCE Stock Holding History

PNC Financial Services Group’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$949 Buy
69
+59
+590% +$874 ﹤0.01% 5004
2026
Q2 		$159 Buy
+10
New +$161 ﹤0.01% 5119
2025
Q3 		– Sell
-65
Closed -$724 – 5187
2025
Q2 		$724 Buy
+65
New +$813 ﹤0.01% 4620

Other funds holding NPCE

Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

PNC Financial Services Group's NPCE Position: Q3 2026 in Review

PNC Financial Services Group increased its Neuropace (NPCE) stake by 590% in Q3 2026, buying an estimated $874 and bringing the position to 69 shares worth $949. The position accounts for ﹤0.01% of the portfolio, ranked #5004.

PNC Financial Services Group first reported a position in NPCE in Q2 2025 and has held it in 3 quarters since. 68 funds tracked by Wall St. Rank hold NPCE as of Q3 2026.

  • PNC Financial Services Group held 69 shares of Neuropace worth $949 as of Q3 2026.
  • PNC Financial Services Group bought 59 Neuropace shares in Q3 2026, an estimated $874.
  • Neuropace made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #5004 holding.
  • PNC Financial Services Group first reported a position in Neuropace in Q2 2025 and has held it in 3 quarters since.
  • 68 funds tracked by Wall St. Rank held Neuropace as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.